|
[2-[[(1R,2R)-2-methylcyclohexyl]carbamoylamino]-2-oxoethyl] 4-oxo-3-phenylphthalazine-1-carboxylate |
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
Compound 2357 (internal name in literature) |
Depiction based on curated SMILES
Cl
N
N
NH
O
N
CH
3
O
N
N
N
CH
3
O
O
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Case HB, et al. 2020. Biochemistry |
|
Shionone |
Depiction based on curated SMILES
CH
3
CH
3
CH
3
CH
3
CH
3
H
3
C
CH
3
H
O
H
CH
3
H
|
Streptococcus |
Pneumolysin |
Preclinical (in vivo) |
Du R, et al. 2022. Molecules |
|
Carfilzomib |
Depiction based on curated SMILES
CH
3
H
3
C
N
H
O
HN
O
N
O
O
CH
3
O
O
CH
3
NH
CH
3
N
H
O
|
Streptococcus |
Adherence |
Preclinical (in vivo) |
Manzer HS, et al. 2022. PLoS Pathog |
|
Kaempferol |
Depiction based on curated SMILES
OH
OH
O
O
HO
HO
|
Listeria Streptococcus |
LLO (Listeriolysin O) Pneumolysin |
Preclinical (in vivo) Preclinical (in vivo) |
Wang T, et al. 2022. Microbiol Spectr Xu L, et al. 2023. Microbes Infect |
|
Linalool |
Depiction based on curated SMILES
CH
3
H
3
C
CH
2
OH
CH
3
|
Streptococcus |
Biofilm |
Preclinical (in vivo) |
Praseetha S, et al. 2023. Antibiotics (Basel) |
|
N-Dodecyl-4-(2-amino-1H-imidazole-4-yl)butanamide |
Depiction based on curated SMILES
N
H
N
H
2
N
N
H
O
CH
3
|
Streptococcus |
Biofilm |
Preclinical (in vivo) |
Liu C, et al. 2023. mBio |
|
4-(2-amino-1H-imidazol-5-yl)-N-hexadecylbutanamide |
Depiction based on curated SMILES
N
H
2
N
N
H
O
N
H
CH
3
|
Streptococcus |
Biofilm |
Preclinical (in vivo) |
Liu C, et al. 2023. mBio |
|
4-(2-amino-1H-imidazol-5-yl)-N-octadecylbutanamide |
Depiction based on curated SMILES
N
H
2
N
N
H
O
N
H
CH
3
|
Streptococcus |
Biofilm |
Preclinical (in vivo) |
Liu C, et al. 2023. mBio |
|
4-(2-amino-1H-imidazol-5-yl)-N-tetradecylbutanamide |
Depiction based on curated SMILES
N
H
2
N
N
H
O
N
H
CH
3
|
Streptococcus |
Biofilm |
Preclinical (in vivo) |
Liu C, et al. 2023. mBio |
|
| | |